BCL2L1 and acute myeloid leukemia: To determine whether AML cells would naturally acquire resistance to ABT-199through modulation of MCL-1 and BCL-XL, we established a panel ofresistant cell lines by exposing six AML cell lines to increasing doses ofABT-199 over several months.